Clinical Trials expand_more

Research Sites expand_more

Investigators expand_more

Vendors expand_more

Sponsors expand_more

Patient Organisations expand_more

Main page
/MedDRA PTs
/Homologous recombination deficiency positive advanced ovarian cancer

Homologous recombination deficiency positive advanced ovarian cancer

PoprzedniHepatitis B

NastepnyMucopolysaccharidosis III

Got a question for us?

Our team reads every message.

Clinical Research

The website is published by:

CTIN POLAND sp. z o.o.

with its registered office in Warsaw,

ul. rtm. Witolda Pileckiego 67/109,

02-781 Warsaw, Poland,

entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,

REGON: 528919042, NIP (Tax ID): 9512598637

© 2026 CTIN Poland sp. z o. o.
All rights reserved.

Clinical Research in the EU

Clinical Trials in the EU
Research Site Profiles
Investigator Profiles
Sponsor Profiles
Vendor Profiles
Patient Organisations

Resources

News & Insights
Events Calendar

For Professionals

Feasibility EU
Promote Your Site
Join the Vendor Directory
Partner with us

About & Legal

About
Contact
Terms of Use
Privacy Policy

We use cookies

This site uses cookies to provide the best experience, personalize content and ads, enable social features, and analyze traffic. Data may include your IP address, cookie IDs, and browser data.

Your personal data are processed under our Privacy Policy. By clicking “Accept all”, you consent to cookies and to processing your data for marketing purposes (e.g., ad personalization and performance measurement).

You may withdraw consent and request access, rectification, erasure, or restriction of processing. Details are in our Privacy Policy.